Q2 EARNINGS: Nobel sales down, but margins improve
This article was originally published in Clinica
Executive Summary
Dental implant specialist and rumored takeover target Nobel Biocare has reported a mixed second quarter: revenues of €144.3m ($191.5m) were below predictions of €148m and also down 2% year-on-year. But on the positive side, the company improved its margins and has raised expectations for the rest of the year.